Journal article
Economic Evaluation of Anastrozole Versus Tamoxifen for Early Stage Breast Cancer in Singapore
Abstract
OBJECTIVES: In Singapore, breast cancer is the leading female malignancy and its incidence has increased threefold over the past decades. For treatment of postmenopausal, hormone receptor positive early stage breast cancer, tamoxifen or aromatase inhibitors such as anastrozole are prescribed either as first-line therapy or sequentially. Currently, anastrozole is patented with a higher drug cost compared with tamoxifen. Hence, the aim of this …
Authors
Shih V; Chan A; Xie F; Ko Y
Journal
Value in Health Regional Issues, Vol. 1, No. 1, pp. 46–53
Publisher
Elsevier
Publication Date
May 2012
DOI
10.1016/j.vhri.2012.03.013
ISSN
2212-1099